Benedito Carneiro
Brown University · Northwestern University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Benedito Carneiro as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:14 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04253262 · A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate CancerBrown University · active not recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT02720484 · Nivolumab in Treating Patients With Metastatic Adrenocortical CancerNorthwestern University · terminated · Metastatic Carcinoma in the Adrenal Cortex, Recurrent Adrenal Cortex Carcinoma, Stage III Adrenal Cortex Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA060553 · NCI · NORTHWESTERN UNIVERSITY · PI Aleksandar Zafirovski · fiscal years 2012 to 2026Named on NCT02720484
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:14 UTC. The ranking covers the 200 most relevant of 26 PubMed records, and a shared surname and initials can bring in a namesake. All 26 on PubMed
- Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.Nat Med · 2023104 citationsRCR 7.4
- Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial.J Clin Endocrinol Metab · 201991 citationsRCR 3.3
- Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors.J Immunother Cancer · 202455 citationsRCR 5.6
- Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study.J Affect Disord · 202354 citationsRCR 7.6
- A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.Clin Cancer Res · 202235 citationsRCR 1.9
- 30 citationsRCR 2.5
- Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors.J Immunother Cancer · 202428 citationsRCR 3.4
- Arketamine for bipolar depression: Open-label, dose-escalation, pilot study.J Psychiatr Res · 202327 citationsRCR 3.6
- Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.Invest New Drugs · 202225 citationsRCR 1.7
- Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).J Natl Cancer Inst · 202416 citationsRCR 1.7